<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">02272</article-id><article-id pub-id-type="doi">10.7554/eLife.02272</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>SM proteins Sly1 and Vps33 co-assemble with Sec17 and SNARE complexes to oppose SNARE disassembly by Sec18</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-10657"><name><surname>Lobingier</surname><given-names>Braden T</given-names></name><aff><addr-line><named-content content-type="department">Department of Biochemistry</named-content></addr-line>, <institution>University of Washington School of Medicine</institution>, <addr-line><named-content content-type="city">Seattle</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-10658"><name><surname>Nickerson</surname><given-names>Daniel P</given-names></name><aff><addr-line><named-content content-type="department">Department of Biochemistry</named-content></addr-line>, <institution>University of Washington School of Medicine</institution>, <addr-line><named-content content-type="city">Seattle</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-10659"><name><surname>Lo</surname><given-names>Sheng-Ying</given-names></name><aff><addr-line><named-content content-type="department">Department of Biochemistry</named-content></addr-line>, <institution>University of Washington School of Medicine</institution>, <addr-line><named-content content-type="city">Seattle</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-1320"><name><surname>Merz</surname><given-names>Alexey J</given-names></name><aff><addr-line><named-content content-type="department">Department of Biochemistry</named-content></addr-line>, <institution>University of Washington School of Medicine</institution>, <addr-line><named-content content-type="city">Seattle</named-content></addr-line>, <country>United States</country><email>merza@uw.edu</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1114"><name><surname>Jahn</surname><given-names>Reinhard</given-names></name><role>Reviewing editor</role><aff><institution>Max Planck Institute for Biophysical Chemistry</institution>, <country>Germany</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>16</day><month>05</month><year>2014</year></pub-date><volume>3</volume><elocation-id>e02272</elocation-id><supplementary-material><ext-link xlink:href="elife-02272-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>12</day><month>01</month><year>2014</year></date><date date-type="accepted"><day>13</day><month>05</month><year>2014</year></date></history><permissions><copyright-statement>Copyright © 2014, Lobingier et al</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Lobingier et al</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Secretory and endolysosomal fusion events are driven by SNAREs and cofactors, including Sec17 (α-SNAP), Sec18 (NSF), and Sec1/Munc18 (SM) proteins. SMs are essential for fusion in vivo, but the basis of this requirement is enigmatic. We now report that, in addition to their established roles as fusion accelerators, SM proteins Sly1 and Vps33 directly shield SNARE complexes from Sec17- and Sec18-mediated disassembly. In vivo, wild-type Sly1 and Vps33 function are required to withstand overproduction of Sec17. In vitro, Sly1 and Vps33 impede SNARE complex disassembly by Sec18 and ATP. Unexpectedly, Sec17 directly promotes selective loading of Sly1 and Vps33 onto cognate SNARE complexes. A large thermodynamic barrier limits SM binding, implying that significant conformational rearrangements are involved. In a working model, Sec17 and SMs accelerate fusion mediated by cognate SNARE complexes and protect them from NSF-mediated disassembly, while mis-assembled or non-cognate SNARE complexes are eliminated through kinetic proofreading by Sec18.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>S. cerevisiae</italic></kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></back></article>